IGHV3-13
Immunoglobulin heavy variable 3-13
Also known as: HV313_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P01766
- Gene
- IGHV3-13
- Ensembl
- ENSG00000211942
- Chromosome
- 14
- Canonical length
- 116 aa
- Protein class
- Immunoglobulin genes, Predicted secreted proteins
- Secretome location
- Immunoglobulin genes
OverviewNCBI Gene
Predicted to enable antigen binding activity. Predicted to be involved in immunoglobulin mediated immune response. Located in blood microparticle. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
116 residues, UniProt reviewed canonical sequence.
>P01766|IGHV3-13
1 MELGLSWVFL VAILEGVQCE VQLVESGGGL VQPGGSLRLS CAASGFTFSS YDMHWVRQAT
61 GKGLEWVSAI GTAGDPYYPG SVKGRFTISR ENAKNSLYLQ MNSLRAGDTA VYYCARLocalizationUniProt · AlphaFold · HPA
Whether an antibody against IGHV3-13 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Highest tissue expression
- 128 nTPM
Expression across tissuesHPA
Tissue
- tonsil: 128 nTPM
- urinary bladder: 85 nTPM
- colon: 63 nTPM
- spleen: 52 nTPM
- duodenum: 47 nTPM
- stomach: 40 nTPM
Single-cell type
- plasma cells: 2.7 nCPM
- b-cells: 0.1 nCPM
- adipocytes: 0 nCPM
- adrenal cortex cells: 0 nCPM
- adrenal medulla cells: 0 nCPM
- alveolar cells type 1: 0 nCPM
Immune cell
- naive B-cell: 20 nTPM
- memory B-cell: 19 nTPM
- total PBMC: 2.4 nTPM
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
Brain region
- cerebral cortex: 0.2 nTPM
- midbrain: 0.2 nTPM
- spinal cord: 0.2 nTPM
- amygdala: 0.1 nTPM
- choroid plexus: 0.1 nTPM
- medulla oblongata: 0.1 nTPM
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads IGHV3-13 as an antibody target. Whether an autoantibody or antibody against IGHV3-13 could matter depends on whether native IGHV3-13 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
IGHV3-13 is annotated at the cell surface, where native IGHV3-13 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label IGHV3-13 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...